Mark Sabag, a notable insider at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), executed a sale of 144,180 shares on May 4, 2026. The transaction, priced at $34.99 per share, amounted to approximately $5.04 million.
This sale adds to a pattern of recent divestitures by company insiders. Earlier in the week, Christine Fox sold 21,258 shares, and prior to that, Sabag himself sold shares in March.
Insider sales can be motivated by a variety of factors, including personal financial planning, diversification of holdings, or the execution of pre-arranged trading plans. Such transactions do not necessarily indicate a shift in the insider's or the company's future performance outlook.